REQUEST A DEMO
Total
USD $0.00
Search more companies

Anyeon Care Co., Ltd. (South Korea)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Anyeon Care Co., Ltd. Profile Updated: December 09, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Anyeon Care Co., Ltd. is a company in South Korea, with a head office in Seoul. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. Anyeon Care Co., Ltd. was incorporated on July 01, 1992. 142 (2024) employees currently work for Anyeon Care Co., Ltd.. From the latest financial highlights, Anyeon Care Co., Ltd. reported a net sales revenue increase of 17.82% in 2023. Its total assets grew by 10.34% over the same period.

Headquarters
10, Tongil-ro Jung-gu Seoul
Seoul; Seoul;

Contact Details: Purchase the Anyeon Care Co., Ltd. report to view the information.

Website: http://www.allencare.co.kr

Basic Information
Total Employees:
Purchase the Anyeon Care Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Anyeon Care Co., Ltd. report to view the information.
Registered Capital:
Purchase the Anyeon Care Co., Ltd. report to view the information.
Incorporation Date:
July 01, 1992
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
51%
Purchase this report to view the information.
49%
Subsidiaries
Gradiant Bioconvergence Inc.
Gradiant Corporation
Therapex Co., Ltd.
Company Performance
Financial values in the chart are available after Anyeon Care Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
17.82%
Total operating revenue
17.82%
Operating profit (EBIT)
15.27%
EBITDA
10.7%
Net Profit (Loss) for the Period
17.82%
Total assets
10.34%
Total equity
23.7%
Operating Profit Margin (ROS)
-0.1%
Net Profit Margin
0%
Return on Equity (ROE)
-3.28%
Debt to Equity Ratio
-22.81%
Quick Ratio
0.02%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?